Nick Abedi, MD | |
2350 Regency Rd Ste A, Lexington, KY 40503-2351 | |
(859) 278-4960 | |
(859) 523-2277 |
Full Name | Nick Abedi |
---|---|
Gender | Male |
Speciality | Vascular Surgery |
Experience | 22 Years |
Location | 2350 Regency Rd Ste A, Lexington, Kentucky |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366605271 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 40942 (Kentucky) | Secondary |
2086S0129X | Surgery - Vascular Surgery | 40942 (Kentucky) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Joseph Hospital | Lexington, KY | Hospital |
Baptist Health Lexington | Lexington, KY | Hospital |
Georgetown Community Hospital | Georgetown, KY | Hospital |
Saint Joseph London | London, KY | Hospital |
Saint Joseph East | Lexington, KY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
United Surgical Associates Psc | 1355248675 | 12 |
News Archive
Cancer Research UK scientists have for the first time developed a treatment that transports 'tumour busting' genes selectively to cancer cells, according to a study published online in Cancer Research.
HealthYes!®, a leading preventive medical screening company, is bringing its life-saving mobile screening services to Colorado. Leveraging the most medically advanced, state-of-the-art equipment and techniques in the industry, HealthYes! screens its clients for life-threatening medical conditions and diseases including: heart disease, stroke, abdominal aortic aneurysm, peripheral artery disease, diabetes and liver disease along with osteoporosis.
Heart and liver transplant recipients are at particularly high risk of developing lung cancer after receiving the donated organ, researchers report at the 2nd European Lung Cancer Conference. They are advising doctors to screen for such cancers in these patients to maximize the chance of detecting the malignancy early.
Adults aged 45 and over starting new sexual relationships are taking chances with their sexual health and are at risk of getting sexually transmitted infections, reveals new research from the Royal Pharmaceutical Society of Great Britain (RPSGB).
A new drug could aid in losing weight and keeping it off. The drug, described in the journal Cell Metabolism on July 26, increases sensitivity to the hormone leptin, a natural appetite suppressant found in the body. Although so far the new drug has only been tested on mice, the findings have implications for the development of new treatments for obesity in humans.
› Verified 3 days ago
Entity Name | United Surgical Associates Psc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831140565 PECOS PAC ID: 1355248675 Enrollment ID: O20031216000094 |
News Archive
Cancer Research UK scientists have for the first time developed a treatment that transports 'tumour busting' genes selectively to cancer cells, according to a study published online in Cancer Research.
HealthYes!®, a leading preventive medical screening company, is bringing its life-saving mobile screening services to Colorado. Leveraging the most medically advanced, state-of-the-art equipment and techniques in the industry, HealthYes! screens its clients for life-threatening medical conditions and diseases including: heart disease, stroke, abdominal aortic aneurysm, peripheral artery disease, diabetes and liver disease along with osteoporosis.
Heart and liver transplant recipients are at particularly high risk of developing lung cancer after receiving the donated organ, researchers report at the 2nd European Lung Cancer Conference. They are advising doctors to screen for such cancers in these patients to maximize the chance of detecting the malignancy early.
Adults aged 45 and over starting new sexual relationships are taking chances with their sexual health and are at risk of getting sexually transmitted infections, reveals new research from the Royal Pharmaceutical Society of Great Britain (RPSGB).
A new drug could aid in losing weight and keeping it off. The drug, described in the journal Cell Metabolism on July 26, increases sensitivity to the hormone leptin, a natural appetite suppressant found in the body. Although so far the new drug has only been tested on mice, the findings have implications for the development of new treatments for obesity in humans.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Nick Abedi, MD 2350 Regency Rd Ste A, Lexington, KY 40503-2351 Ph: (859) 278-4960 | Nick Abedi, MD 2350 Regency Rd Ste A, Lexington, KY 40503-2351 Ph: (859) 278-4960 |
News Archive
Cancer Research UK scientists have for the first time developed a treatment that transports 'tumour busting' genes selectively to cancer cells, according to a study published online in Cancer Research.
HealthYes!®, a leading preventive medical screening company, is bringing its life-saving mobile screening services to Colorado. Leveraging the most medically advanced, state-of-the-art equipment and techniques in the industry, HealthYes! screens its clients for life-threatening medical conditions and diseases including: heart disease, stroke, abdominal aortic aneurysm, peripheral artery disease, diabetes and liver disease along with osteoporosis.
Heart and liver transplant recipients are at particularly high risk of developing lung cancer after receiving the donated organ, researchers report at the 2nd European Lung Cancer Conference. They are advising doctors to screen for such cancers in these patients to maximize the chance of detecting the malignancy early.
Adults aged 45 and over starting new sexual relationships are taking chances with their sexual health and are at risk of getting sexually transmitted infections, reveals new research from the Royal Pharmaceutical Society of Great Britain (RPSGB).
A new drug could aid in losing weight and keeping it off. The drug, described in the journal Cell Metabolism on July 26, increases sensitivity to the hormone leptin, a natural appetite suppressant found in the body. Although so far the new drug has only been tested on mice, the findings have implications for the development of new treatments for obesity in humans.
› Verified 3 days ago
Keith Menes, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2350 Regency Rd Ste A, Lexington, KY 40503 Phone: 859-278-4960 Fax: 859-523-2277 | |
Melissa Ranney Newcomb, MD Surgery Medicare: Medicare Enrolled Practice Location: Ukmc General Surgery, 800 Rose St., Lexington, KY 40536 Phone: 859-323-6346 Fax: 859-323-6840 | |
Cheryl Diana Richie, Surgery Medicare: Accepting Medicare Assignments Practice Location: 138 Leader Ave, Lexington, KY 40508 Phone: 859-323-5261 | |
Dr. Varun Jain, M.D Surgery Medicare: Medicare Enrolled Practice Location: 740 S Limestone Ste L104, Lexington, KY 40536 Phone: 859-257-3253 Fax: 859-323-1203 | |
Wanda Lam, MD Surgery Medicare: Medicare Enrolled Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-257-3253 Fax: 859-323-1203 | |
David J Worhunsky, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-323-5625 | |
Veronica Morgan Jones, MD Surgery Medicare: Medicare Enrolled Practice Location: 800 Rose St Whitney Hendrickson Ste 134, Lexington, KY 40536 Phone: 859-323-6346 Fax: 859-323-6840 |